Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
Titel:
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
Auteur:
Schwarz, M. Schwarz, C. Schütz, A. Schwanke, C. Krabb, E. Schubert, R. Liebich, S.-T. Bauer, D. Burghart, L. Brinkmann, L. Gutic, E. Reiberger, T. Haltmayer, H. Gschwantler, M.